Alvaro Quintanal-Villalonga Selected Research

Aromatase Inhibitors

1/2023

Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alvaro Quintanal-Villalonga Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 12/2017
5	Lung Neoplasms (Lung Cancer) 10/2023 - 12/2017
3	Adenocarcinoma 01/2023 - 01/2019
3	Adenocarcinoma of Lung 01/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2023
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2021
1	Small Cell Carcinoma 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2019

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2017
2	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2023
2	osimertinibIBA 01/2023 - 10/2021
2	selinexorIBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2017
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2017
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Small Cytoplasmic RNAIBA 10/2023
1	B7-H1 AntigenIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Aromatase InhibitorsIBA 01/2023
1	Exportin 1 ProteinIBA 01/2023
1	enzalutamideIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 10/2019
1	Co-Repressor ProteinsIBA 10/2019
1	APOBEC-1 DeaminaseIBA 10/2019
1	Cytidine DeaminaseIBA 10/2019
1	LigandsIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019
1	neurabinIBA 12/2017
1	Adenosine Triphosphate (ATP)IBA 12/2017

Therapy/Procedure

5	Therapeutics 10/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2022
1	Immunotherapy 10/2023